Serodia Atg

FDA 510(k) K953066 · Fujirebio America, Inc.

Substantially Equivalent

510(k) numberK953066

Submission

Device name
Serodia Atg
Applicant
Fujirebio America, Inc.
West Cadwell, NJ, US
Received
June 30, 1995
Decision date
August 14, 1995
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DDC – Thyroglobulin, Antigen, Antiserum, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5870
Specialty
Immunology

Other 510(k)s with product code DDC

510(k)DeviceApplicantDecision
K023592Seraquest Anti-ThyroglobulinDDC · Traditional Quest Intl., Inc.01/06/2003SE
K012208Access Thyroglobulin Antibody and Calibrators on the Access Immunoassay Systems, Models…DDC · Traditional Beckman Coulter, Inc.09/07/2001SE
K000363Modification to Zeus Scientific, Inc., Thyroglobulin Igg Elisa Test SystemDDC · Special Zeus Scientific, Inc.02/18/2000SE
K991610Zeus Scientific Inc., Tpo Igg Elisa Test System.DDC · Traditional Zeus Scientific, Inc.06/25/1999SE
K991179Zeus Scientific, Inc., Thyroglobulin Igg Elisa Test SystemDDC · Traditional Zeus Scientific, Inc.06/17/1999SE
K971835Anti-Thyroglobulin (TG) Microplate ElisaDDC · Traditional Monobind07/03/1997SE
K943625Autostat II Anti-ThyroglobulinDDC · Traditional Cogent Diagnotics , Ltd.12/22/1994SE
K936010Thyroglobulin Autoantibody Enzyme ImmunoassayDDC · Traditional Biomerica, Inc.07/18/1994SE
K930486Quanta Lite(Tm) Thyroid T ElisaDDC · Traditional Inova Diagnostics, Inc.03/15/1993SE
K865020Sera-Tek Thyroglobulin Antibody TestDDC · Traditional Miles Laboratories, Inc.02/02/1987SE

More from Miles Laboratories, Inc.

510(k)DeviceDecision
K905038Olympus Pk-Tp Absorbent KitGMT · Traditional 05/06/1991SE

Questions and answers

When was Serodia Atg cleared by the FDA?

Serodia Atg (K953066) received a 510(k) decision of Substantially Equivalent on August 14, 1995, 45 days after the submission was received.

What is the product code of K953066?

The FDA product code is DDC – Thyroglobulin, Antigen, Antiserum, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5870.